Zu den Deals
Gesundheitswesen

PanTera secures US$104.1 million in oversubscribed Series A round to accelerate global actinium-225 production

PanTera, a Belgian radioisotope producer, has completed a US$104.1 million (€93 million) oversubscribed Series A fundraising round led by EQT Life Sciences. Additional equity and debt funding brings the total amount raised to US$150 million (€134 million). In addition to EQT Life Sciences, the Series A round was also joined by Kurma Partners, Eurazeo, Korys, Paladin and PMV.

PanTera, an IBA and SCK CEN joint venture, aims to secure the large-scale production of actinium-225 (225Ac), which is one of the most promising alpha-emitting radioisotopes to fight cancer. The funds raised will be used primarily toward the construction of a state-of-the-art production facility in Belgium. This facility will not only enable large-scale production, it will also help fulfill PanTera’s ultimate goal to improve the accessibility of future, innovative cancer therapy based on 225Ac and theranostics.

Oaklins’ team in Belgium acted as the sole financial advisor in this transaction.

Sprechen Sie mit dem Deal-Team

Cédric Michils

Geschäftsführer
Brüssel, Belgien
Oaklins KBC Securities

Bart Delusinne

Geschäftsführer
Brüssel, Belgien
Oaklins KBC Securities

Nicolas Lambers

Associate Director
Brüssel, Belgien
Oaklins KBC Securities

Michaël Rixhon

Associate Director
Brüssel, Belgien
Oaklins KBC Securities

Nicholas Matthyssens

Senior Associate
Brüssel, Belgien
Oaklins KBC Securities

Robin Bundervoet

Associate
Brüssel, Belgien
Oaklins KBC Securities

Niels Maes

Associate
Brüssel, Belgien
Oaklins KBC Securities

Relevante Transaktionen

Bayer AG has entered into a takeover agreement with Cara Care
Gesundheitswesen | Technologie, Medien und Telekommunikation

Bayer AG has entered into a takeover agreement with Cara Care

Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.

Weitere Informationen
Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
Gesundheitswesen

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.

NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.

Weitere Informationen
Springwell Veterinary Surgery has been transferred to an Employee Ownership Trust
Konsumgüter & Handel | Gesundheitswesen

Springwell Veterinary Surgery has been transferred to an Employee Ownership Trust

Springwell Veterinary Surgery has become employee owned after transferring into an Employee Ownership Trust (EOT).

Weitere Informationen